Anika Therapeutics, Inc.

ANIK·NASDAQ·$14.89Share Price as of 11/2·$198MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2607/29/26 10-QQ1 ended 03/31/2604/30/26 10-KFY 202503/03/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2507/30/25

Disclosures

8-KCurrent report07/29/26 8-KCurrent report07/14/26 8-KCurrent report06/23/26 8-KCurrent report04/29/26 8-KCurrent report02/26/26

Prospectuses and Registrations

S-8Registration of securities for employees07/29/26 S-8Registration of securities for employees11/05/25 S-8Registration of securities for employees05/31/24 S-8 POSPost-effective amendment (S-8)01/22/24 S-8Registration of securities for employees01/19/24

Proxies

DEFA14AAdditional proxy materials06/08/26 DEFA14AAdditional proxy materials06/01/26 DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/28/25

Ownership

144Proposed sale of securities08/07/26 Form 4Insider transaction08/05/26 SC 13G/ABeneficial ownership (amended)07/31/26 SC 13G/ABeneficial ownership (amended)07/17/26 Form 4Insider transaction06/23/26

Other

ARSAnnual report to shareholders04/28/26 UPLOADLetter from the SEC07/24/25 CORRESPCorrespondence with the SEC07/17/25 UPLOADLetter from the SEC06/18/25 ARSAnnual report to shareholders04/28/25